Document Type
Article
Publication Date
5-11-2023
Abstract
Background: During the COVID-19 pandemic, opioid-related overdose deaths increased. Although Medication-Assisted Treatment or Recovery (MAT or MAR) is available, initiation and retention rates vary. The goal of this study was to evaluate clinical, demographic, and Social Determinant of Health factors affecting MAR initiation, on-time initiation of medications, and successful retention in the program. The secondary goal was to evaluate the impact of a novel interprofessional practice model incorporating pharmacists. Methods: A retrospective analysis was conducted using electronic health record data from a pilot MAR Program initiated within a California Federally Qualified Healthcare Center. Results: From September 2019 to August 2020, 48 patients enrolled into the program. On-time initiation of medications occurred in 68% of patients and average program retention was 96.4 ± 95.8 days. Patients currently using opioids (p = 0.005) and those receiving supportive medications (p = 0.049) had lower odds of on-time MAR initiation. There were no statistically significant factors associated with successful retention in the program. The number of visits with members of the interprofessional team did not significantly affect on-time initiation or successful retention. Conclusions: Current opioid use and receipt of supportive medications were associated with lower on-time medication initiation. Further studies are warranted to explore additional factors which may affect initiation and retention.
Recommended Citation
Nguyen T, Cheetham TC, Fawaz S, Beuttler R, Xavioer S. Factors affecting initiation and retention of Medication-Assisted Recovery (MAR) within a pilot pharmacist-involved practice model at a Federally Qualified Healthcare Center (FQHC) during the COVID-19 pandemic. Healthcare (Basel). 2023;11(10):1393. https://doi.org/10.3390/healthcare11101393
Copyright
The authors
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Included in
Epidemiology Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Pharmacy Administration, Policy and Regulation Commons, Substance Abuse and Addiction Commons
Comments
This article was originally published in Healthcare (Basel), volume 11, issue 10, in 2023. https://doi.org/10.3390/healthcare11101393
This scholarship is part of the Chapman University COVID-19 Archives.